clinicalmedicine
-
New Migraine Drug Can Even Tackle the Most Difficult Cases, Study Finds
A recently approved preventative migraine drug called atogepant (branded Qulipta) seems to help even the most difficult cases, preliminary research out this week has found. The study showed that patients who hadn’t responded to other treatments experienced noticeably fewer days without migraine while on atogepant than those given a placebo. The Food and Drug Administration…
-
Apple Makes Strides Toward a Glucose-Tracking Smartwatch for Diabetics
Apple is reportedly close to creating a noninvasive glucose test for diabetics through a new sensor on its Apple Watch. The technology has been in the works since 2010, when then-Apple CEO and founder Steve Jobs bought out RareLight, a small startup that crafted ideas for noninvasive blood glucose monitoring.
-
New mRNA Cancer Vaccine Passes Important Human Trial
In patients with advanced melanoma, the vaccine along with immunotherapy reduced the risk of cancer recurrence and death by 44%, the companies said.
-
A Major Trial Shows Mixed Results for Colonoscopy in Preventing Cancer Deaths
A large, 10-year randomised trial has found that simply recommending a common screening procedure for colorectal cancer may not be as beneficial for the general public as hoped for. The study found no difference in cancer death rates between healthy middle-aged people who were or weren’t offered a colonoscopy, though those offered a colonoscopy did…